Skip to main content
Pharmafile

Is the Current EU Legal Framework for Orphan Medicines Fit for Purpose?

Autumn 2019
著者
Maria Isabel ManleyDr. Chris Boyle

Maria Isabel Manley, partner and head of the UK Global Life Sciences Practice, and Chris Boyle, associate, at Sidley, discuss the impact of regulatory frameworks on medicines for rare diseases.

View Article

連絡先

Manley, Maria Isabel
パートナー
Boyle, Chris
パートナー

得意分野

Suggested News & Insights

Sidley Lawyers Joshua Hofheimer and Dino LaVerghetta to Speak at Doon Insights' Ag & Food Tech 13 WorkshopWednesday, May 27, 2026 - Thursday, May 28, 2026
Events
EU Pharma Package: Compromise Text Published – Best Efforts Required (Part 2)May 18, 2026
GoodLifeSci
Growth Meets Guardrails: Getting You Ready for the New Realm of Ad/PromoWednesday, May 13, 2026
Events
Sidley Represents MacroGenics in the Sale of Its GMP Manufacturing OperationsMay 11, 2026
Announcements
Sidley Represents Underwriters in Connection With Pharvaris’ US$115 Million Underwritten Offering of Ordinary SharesMay 8, 2026
Announcements
Sidley Represents Archimed in US$1.1 Billion Acquisition of Esperion TherapeuticsMay 1, 2026
Announcements